Lloyd John, Cheyne James
7 Avenue Pasteur 71700 Tournus, France.
Vaccine. 2017 Apr 19;35(17):2115-2120. doi: 10.1016/j.vaccine.2016.11.097.
International efforts to eradicate smallpox in the 1960s and 1970s provided the foundation for efforts to expand immunization programmes, including work to develop immunization supply chains. The need to create a reliable system to keep vaccines cold during the lengthy journey from the manufacturer to the point of use, even in remote areas, was a crucial concern during the early days of the Expanded Programme on Immunization. The vaccine cold chain was deliberately separated from other medical distribution systems to assure timely access to and control of vaccines and injection materials. The story of the early development of the vaccine cold chain shows how a number of challenges were overcome with technological and human resource solutions. For example, the lack of methods to monitor exposure of vaccines to heat during transport and storage led to many innovations, including temperature-sensitive vaccine vial monitors and better methods to record and communicate temperatures in vaccine stores. The need for appropriate equipment to store and transport vaccines in tropical developing countries led to innovations in refrigeration equipment as well as the introduction and widespread adoption of novel high performance vaccine cold-boxes and carriers. New technologies also helped to make injection safer. Underlying this work on technologies and equipment was a major effort to develop the human resources required to manage and implement the immunization supply chain. This included creating foundational policies and a management infrastructure; providing training for managers, health workers, technicians, and others. The vaccine cold chain has contributed to one of the world's public health success stories and provides three priority lessons for future: the vaccine supply chain needs to be integrated with other public health supplies, re-designed for efficiency and effectiveness and work is needed in the longer term to eliminate the need for refrigeration in the supply chain.
20世纪60年代和70年代开展的全球根除天花行动,为扩大免疫规划工作奠定了基础,其中包括发展免疫供应链的工作。在扩大免疫规划早期,一个至关重要的问题是需要建立一个可靠的系统,以便在疫苗从生产商到使用点的漫长运输过程中,即使是在偏远地区,也能保持疫苗处于低温状态。疫苗冷链有意与其他医疗配送系统分开,以确保能及时获取并管控疫苗及注射材料。疫苗冷链早期发展历程表明,通过技术和人力资源解决方案克服了诸多挑战。例如,由于缺乏监测疫苗在运输和储存过程中受热情况的方法,催生了许多创新,包括热敏疫苗瓶监测器以及记录和传达疫苗储存温度的更好方法。热带发展中国家对储存和运输疫苗的适当设备的需求,推动了制冷设备的创新,以及新型高性能疫苗冷藏箱和运输箱的引入和广泛应用。新技术也有助于使注射更安全。在这些技术和设备工作的背后,是为培养管理和实施免疫供应链所需的人力资源而做出的重大努力。这包括制定基础政策和管理基础设施;为管理人员、卫生工作者、技术人员及其他人员提供培训。疫苗冷链促成了全球公共卫生的一个成功案例,并为未来提供了三个优先经验教训:疫苗供应链需要与其他公共卫生用品整合,重新设计以提高效率和效力,并且从长远来看,需要开展工作以消除供应链中对冷藏的需求。